22 related articles for article (PubMed ID: 21846617)
1. Effect of the Concomitant Use of Subcutaneous Basal Insulin and Intravenous Insulin Infusion in the Treatment of Severe Hyperglycemic Patients.
Lim Y; Ohn JH; Jeong J; Ryu J; Kim SW; Cho JH; Park HS; Kim HW; Lee J; Kim ES; Kim NH; Jo YH; Jang HC
Endocrinol Metab (Seoul); 2022 Jun; 37(3):444-454. PubMed ID: 35654578
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effect of insulin glargine and regular insulin on perioperative glycemic control in patients with type 2 diabetes mellitus under insulin treatment during vitrectomy surgery under general anesthesia: A randomized clinical trial study.
Derakhshan P; Khatibi A; Faiz SHR; Rahimzadeh P; Nouri N
Med J Islam Repub Iran; 2021; 35():31. PubMed ID: 34211933
[No Abstract] [Full Text] [Related]
3. Perioperative Management of Diabetes Mellitus: Novel Approaches.
Palermo NE; Garg R
Curr Diab Rep; 2019 Feb; 19(4):14. PubMed ID: 30806818
[TBL] [Abstract][Full Text] [Related]
4. Adult hyperglycemic crisis: a review and perspective.
Steenkamp DW; Alexanian SM; McDonnell ME
Curr Diab Rep; 2013 Feb; 13(1):130-7. PubMed ID: 23115048
[TBL] [Abstract][Full Text] [Related]
5. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
[TBL] [Abstract][Full Text] [Related]
6. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
Yeldandi RR; Lurie A; Baldwin D
Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
[TBL] [Abstract][Full Text] [Related]
7. Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.
Silinskie KM; Kirshner R; Hite MS
Ann Pharmacother; 2013 Jan; 47(1):20-8. PubMed ID: 23324510
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes.
Kudva YC; Basu A; Jenkins GD; Pons GM; Quandt LL; Gebel JA; Vogelsang DA; Smith SA; Rizza RA; Isley WL
Diabetes Care; 2005 Jan; 28(1):10-4. PubMed ID: 15616226
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the dawn phenomenon to the fasting and postbreakfast hyperglycemia in type 1 diabetes treated with once-nightly insulin glargine.
King AB; Clark D; Wolfe GS
Endocr Pract; 2012; 18(4):558-62. PubMed ID: 22548951
[TBL] [Abstract][Full Text] [Related]
10. Long-acting subcutaneously administered insulin for glycemic control immediately after cardiac surgery.
Aggarwal A; Rawn JD; Pendergrass ML; Garg RK
Endocr Pract; 2011; 17(4):558-62. PubMed ID: 21846617
[TBL] [Abstract][Full Text] [Related]
11. Insulin glargine: a systematic review of a long-acting insulin analogue.
Wang F; Carabino JM; Vergara CM
Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
[TBL] [Abstract][Full Text] [Related]
12. Dosing of insulin glargine in the treatment of type 2 diabetes.
Barnett A
Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
